News

FDA Approves Updated Vabysmo Label To Extend Treatment For Macular Edema Following Retinal Vein Occlusion (Rvo) Beyond Six Months

Genentech has received FDA approval of Vabysmo® for the treatment of macular edema due to retinal vein occlusion (RVO) beyond six months. RVO affects over a million Americans and often involves long-term intravitreal therapy to address the chronic nature of the disease. “This label update reinforces our commitment to delivering consistent, long-term solutions for patients [Read More]

PRIMA System Improves Sight in Individuals With Geographic Atrophy

A study involving participants with geographic atrophy due to dry AMD, has shown that a photovoltaic subretinal implant, combined with glasses that project near-infrared light to the implant, has led to significant improvement in visual acuity in 32 participants. This so-called PRIMA system represents the first eye prosthesis to restore functional sight in people with [Read More]

Muhammad’s Story

by Muhammad Hassan Rasheed Diagnosis I’ve had an eye problem since birth. When I was around four months old, my family noticed something wasn’t right. When I used to crawl, I would bump into things, which made them think I might have a vision issue. They took me to the doctor, and that’s when we [Read More]

1 2 3 117